|
Depuy Hip Replacement
Recall
Depuy, a Johnson and Johnson company, issued a voluntary recall of
their ASR hip replacement system in September of 2010. The ASR
hip replacement is a large metal ball that rotates inside a thin
metal shell. The recall was in response to findings in the
British joint registry of an unusually high rate of revisions.
There are multiple possible explanations for this higher than normal
revision rate, which I will address below. The ASR hip
replacement has been available in the United States for about 3
years, so if your hip replacement was preformed before 2007, you are
unaffected by this recall.
The term "recall" to me suggest that some sort of defect was
discovered with this ASR implant. However, that is not the
case. The cause of the poor outcomes is not completely clear.
There are patients that have done and continue to do very well with
their ASR hip replacement, but an unusually high number of patients
are having problems with their ASR hip replacement.
What does a patient with an ASR hip replacement
need to do?
If you have an ASR hip replacement from Depuy, you should have been
notified by your surgeon. Depuy sent out a mailing to all
orthopedic physicians with the name of every ASR patient that
physician had performed and the physicians are expected to notify
their patients. If you have not been notified and are not
certain what type of implant you have, then contact your surgeon or
the hospital where the surgery was preformed.
If you have an ASR hip replacement, you need to contact Depuy and
get a patient reference number so that the cost of the work up of
your ASR hip replacement is covered by Depuy. If you do not
file the paperwork with Depuy, it is possible that your health
insurance company may refuse to pay for your medical bills.
You then need to see an orthopedic surgeon and have your blood
tested for metal ion levels. If the metal ion levels in your
blood are high (>7), then you probably need to consider getting your
hip revised. If your metal ion levels are normal, but you are
having considerable pain, then an ultrasound or metal suppressed MRI
may be ordered to see if you have any fluid around your hip
replacement. If you have fluid around your hip replacement,
you should consider a hip revision. A hip aspiration may also
be preformed. If you have normal metal ion levels and are not
having hip pain, then you should recheck your metal ion levels in a
year or sooner if you develop pain.
Why is the ASR failing at a higher rate than other
hip replacements?
This is a million dollar question that every trial attorney is
trying to answer. I have a few theories, but little facts to
back them up.
First, I think that the problem with the ASR is probably not
isolated to Depuy's large metal on metal components. The whole
family of monoblock acetabular components with a large metal on
metal bearing surface have had some reported problems. About a
year or so ago, Dr. Larry Dorr, a prominent orthopedic physician
from San Diego, sounded the alarm about the Zimmer Durom monoblock
acetabular components. He was seeing a higher than expected
rate of loosening of the acetabular shell. Zimmer initially
said they were not seeing a high failure rate; however, Dr. Dorr
sent out a memo to every orthopedic surgeon in AAHKS stating his
concern with the Durom cup. Zimmer then said that the problem
was with the surgical technique and operating surgeon, but if Dr.
Dorr, who is a world expert at hip replacement, was having problems,
then every orthopedic surgeon would have problems. Zimmer
finally restricted the use of the Durom cup to physicians that
attended a special cadaver lab, which along with the swarm of trial
attorneys basically ended the use of the Durom acetabular shell in
the United States. The Biomet M2M cup also had some reported
problems. This cup has been redesigned, but the earlier
acetabular shell had little cut outs that allowed the cup to be
attached to the insertion handle. These cut outs decreased the
effective articular surface.
These monoblock acetabular cups (Depuy's ASR, Stryker's Cormet,
Smith & Nephew's Birmingham, Zimmer's Durom, Biomet's M2M, Wright's
Conserve) have a couple things in common which could explain some of
their potential problems. First, the acetabular cups are less
than a hemisphere. Most of them are around 158 to 169 degrees,
which is necessary for hip resurfacing. This means there is
less material or acetabular shell to bear the load of the joint.
Less surface area means greater pressure which means more wear.
This increased wear may not be an issue if the components are in
perfect position, but slight changes in the angle of the acetabular
cup may have grave consequences. The reissued Durom cup is now
a full hemisphere. The wear in a metal on metal monoblock cup
is obviously metal ions. Second, these monoblock cups offer
the surgeon great hip stability, which may make surgeons less
concerned with their cup angles because they would not have to worry
about hip dislocations. Third, all of these cups do not offer
additional fixation with screws. The modular acetabular
components allow the surgeon to screw the acetabular cup into the
acetabular bone so that the cup can not move while the bone grows
into the acetabular cup. The monoblock acetabular components
can not have screw holes. Fourth, these monoblock shells are
thinner and more flexible than the modular shells. It is
possible that the shells deform when they are impacted into hard
bone. The tolerance on these monoblock shells is around 60 to
200 microns to improve wear rates. If the shell deforms more
than 60 microns or so, then the bearing surface would experience
equatorial seizing and the motion of the hip joint would cause
considerable shear stress at the bone / acetabular shell interface
and loosen the implants.
Another possibility includes a theoretical problem with the way that
Depuy manufactured the surface of the cup or femoral head. The
polishing of the metal could have been different than other
companies or their tolerance (the difference between the inner
diameter of the cup and the outer diameter of the femoral head)
could have been a little off.
Summary
I am impressed with Depuy's handling of this recall. They have
taken responsibility for the poor outcomes of their implant and
refrained from blaming the surgeon or surgical technique.
These sorts of problems can arise with any new product, but I feel
they have responded in an ethical manner.
|